Citi Upgrades Bellicum Pharmaceuticals (BLCM) to Buy
- AT&T (T) to Acquire Time Warner (TWX) for $107.50/Share
- Rockwell Collins (COL) in Advanced Talks to Acquire B/E Aerospace (BEAV) - WSJ
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Citi upgraded Bellicum Pharmaceuticals (NASDAQ: BLCM) from Neutral to Buy with a price target of $24.00.
Shares of Bellicum Pharmaceuticals closed at $17.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Upgrades PayPal (PYPL) to Buy Following 'Solid' Q3 Results
- Wunderlich Securities Upgrades Microsoft (MSFT) to Buy
- FBR Capital Upgrades NorthStar Realty Finance (NRF) to Outperform